The webinar has been recorded and is available for purchase. Please select the links for pricing and forms.
The European Chemicals Agency (ECHA) has proposed restrictions on the use of microplastics in products used in various market segments - including medicinal products. ECHA's broad definition of microplastics will result in a significant number of excipients falling into the scope of restriction along with increased labeling and reporting requirements for users. In addition, controlled release (CR) medicinal products have been targeted as sources of microplastics.
This webinar will review IPEC's intent to submit comments to ECHA and highlight issues that both users and makers can consider when submitting individual company responses.